BCD-100
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BCD-100, covering 2019-05-09 to 2023-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma [Phase 2]